Dynavax Technologies Corporation (DVAX)
Chart Events
Performance Outlook
| Previous Close | 7.76 |
| Open | 7.86 |
| Bid | 7.96 x 800 |
| Ask | 8.00 x 900 |
| Day's Range | 7.80 - 8.04 |
| 52 Week Range | 2.89 - 12.44 |
| Volume | 766,346 |
| Avg. Volume | 6,133,596 |
| Market Cap | 914.213M |
| Beta (5Y Monthly) | 1.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.78 |
| Earnings Date | Aug 04, 2021 - Aug 09, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.00 |
- Motley Fool
Why Dynavax Technologies Stock Is Sinking Again Today
Shares of Dynavax Technologies (NASDAQ: DVAX) were trading 5.4% lower as of 11:22 a.m. EDT on Tuesday. The decline came after the company announced the pricing of a $200 million offering of senior convertible notes. This represents a 32.5% premium over the closing price of the biotech stock on Monday.
- PR Newswire
Dynavax Announces Pricing of $200 Million Convertible Senior Notes Offering
Dynavax Technologies Corporation ("Dynavax") (Nasdaq: DVAX) today announced the pricing of $200.0 million aggregate principal amount of 2.50% convertible senior notes due 2026 (the "notes") in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Dynavax also granted the initial purchasers of the notes an option to purchase up to an additional $30.0 million aggregate principal amount of notes. The sale of the notes is expected to close on May 13, 2021, subject to customary closing conditions.
- Motley Fool
Why Dynavax Stock Is Nosediving Today
Shares of Dynavax Technologies (NASDAQ: DVAX) were nosediving 18.1% lower as of 11:42 a.m. EDT on Monday. The key word to note in Dynavax's announcement is "convertible." Issuing convertible notes is a common practice for companies, though.
